ATLASATLAS fair value
ATLAS has no fair value for this stock today.
BioHarvest Sciences (BHST)
BioHarvest Sciences stock price today, ATLAS forecast and fair value
Consumer Defensive · Packaged Foods · NASDAQ
$1.70▲ +1.19%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BioHarvest Sciences in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BioHarvest Sciences
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives BioHarvest Sciences a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.51 and $1.87; in 9 out of 10, between $1.25 and $2.26. Estimated annual volatility is 65%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $33.3M
- 52-week high
- $11.40
- 52-week low
- $1.37
- Revenue (12 months)
- $35.5M
- Revenue growth (YoY)
- +37.0%
- Gross margin
- 59.3%
- Operating margin
- -16.2%
- Net margin
- -32.3%
- Return on equity
- -142.5%
- Free cash flow (12 months)
- $-11.8M
- Beta
- 1.35
What this means
ATLAS does not publish a fair value for BHST right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BHST has traded between $1.37 and $11.40. Today it is 85.1% below that high and 24% above its low.
On the business: revenue grew 37.0% year over year; net margin is 32.3%.
Its beta is 1.35: it tends to move more than the market, both up and down.
About the company
BioHarvest Sciences Inc. is a biotechnology company focused on Botanical Synthesis, a proprietary platform used to produce plant-based compounds without growing the underlying plant.
Want to see everything about BioHarvest Sciences?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does BioHarvest Sciences do?
BioHarvest Sciences Inc. is a biotechnology company focused on Botanical Synthesis, a proprietary platform used to produce plant-based compounds without growing the underlying plant.
What is the chance BHST goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, BHST ends the month between $1.51 and $1.87.
How big is BioHarvest Sciences and what is its P/E ratio?
BioHarvest Sciences's market capitalization is $33.3M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is BHST?
ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between $1.51 and $1.87.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer